Reconciliation Action Plan

Our commitment to social responsibility, globally and in the Australian community, is embedded into the way we do business, and we are proud to build our Reconciliation Action Plan (RAP) into our ways of working.

GSK’s vision is to make a tangible difference in the nation’s reconciliation journey by facilitating meaningful relationships built on the pillars of respect and awareness between our organisation and the Aboriginal and Torres Strait Islander community. And capitalise on our expertise in the health landscape to help eliminate the disadvantages and challenges faced by aboriginal and Torres Strait Islander peoples.

To achieve our vision, we will work in partnership with Aboriginal and Torres Strait Islander peoples to implement symbolic and practical measures that build long-lasting relationships, enhance respect and cultural appreciation, and provide valuable opportunities for those within our community. We see our Reconciliation Action Plan (RAP) as an ongoing investment, and admire our colleagues within the business community who have also taken steps to identify, change and promote reconciliation in action. We acknowledge the vital role of Reconciliation Australia in structuring the RAP program to support the efforts of organisations like GSK in implementing measures to work towards reconciliation between Aboriginal and Torres Strait Islander peoples and non-Aboriginal and Torres Strait Islander peoples in Australia.

GSK’s 2018–2020 Innovate RAP is our second RAP, and builds upon the success of our first RAP, which was put in place from 2012–2014.

To demonstrate that we're not just talking the talk but actually walking the walk, we have released a Progress Summary Report. This document provides details of the actions taken towards our Reconciliation Action Plan deliverables in the first half of 2019. 

See the report here: